Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

AstraZeneca

AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas

August 8, 2018 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma

AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
News

Stem cells could ‘reset’ immune system in Crohn’s disease patients

August 8, 2018 Research and Development Crohn’s disease, Stem cells, crohn's disease, trials

A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …
News
congo-river

MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak

August 8, 2018 Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma

MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
News
spark_v2

Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%

August 8, 2018 Research and Development Spark Therapeutics, haemophilia, pharma

Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
News

Drugs should be preferred first-choice treatment for ADHD

August 8, 2018 Research and Development ADHD, adults, amphetmines, children, prescription, ritalin

Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …
News

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Appointment

Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller

August 7, 2018 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma

The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
News
28246711066_52e38bc591_z

MHRA sets out Brexit implementation period plan

August 7, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
News
omeros_logo_home_resized

Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Appointment
diversity_graphic

Enough talk: Action is required to achieve parity in biotech

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Feature
armind_madan

England’s top GP resigns over imflammatory online comments

August 6, 2018 Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
News

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
News
Press release
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
News
shutterstock_212035546

Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold

August 3, 2018 Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …
News
ema_logo

EMA to cut activities as it forecasts loss of 30% of staff

August 2, 2018 Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025